Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.
Choose from the criteria below to find an activity that fits you best.
NOTE: If you attended the live CE activity titled "Making Smart Pumps More Intelligent Using Technology Integration and Pooled Data Analysis" that was held on December 7, 2015 during the 50th ASHP Midyear Clinical Meeting & Exhibition in New Orleans, Louisiana AND received CE credit (i.e. a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-15-255-L05-P), you are NOT allowed to also receive CE credit for this home-study activity.
Smart infusion pumps have several safety limitations, most significantly, they often operate in isolation, unable to interact with other technologies available in healthcare organizations. This activity will explore the challenges and opportunities involved in linking smart pumps with the EHR, CPOE, and barcode medication administration. One of the first hospitals to fully integrate smart pumps will provide insights and strategies for success. A unique online, evidence-based community forum that allows members to pool and interactively analyze infusion pump data in a protected environment also will be discussed.
The target audience for this activity includes pharmacists. Upon completion of this activity, participants will be able to:
Ann Christine Catlin
Senior Research Scientist
Rosen Center for Advanced Computing
West Lafayette, Indiana
Michael R. Cohen, RPh, MS, ScD (hon), DPS (hon), FASHP
Institute for Safe Medication Practices
Christina Michalek, RPh, BS, FASHP
Medication Safety Specialist
Institute for Safe Medication Practices
Tina M. Suess, RN, MHA, CPHIMS
Manager of Medication Safety Integration
Lancaster General Health
It is the policy of ISMP and ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Ann Christine Catlin, Michael Cohen, Christina Michalek, and Tina Suess have no relevant commercial and/or financial relationships to disclose.
Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
Release Date: 02-08-2016
Expiration Date: 02-08-2018
This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-16-020-H05-P has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers, and is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will be given.
This activity is supported by an educational grant from Hospira, a Pfizer company.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.